


immunovant.com
Get leads like Immunovant — and thousands more
Build targeted lists by tech stack, traffic, and more
Immunovant: The $200M Bet on One Target
A biotech startup with a laser focus, a small team, and a massive war chest.
In the high-stakes world of biotech, where diversification is often seen as safety, Immunovant is betting everything on a single molecule. With $200M in funding and a pipeline laser-focused on FcRn inhibition, this isn't a company hedging its bets—it's a company doubling down on a specific mechanism to treat autoimmune diseases.
"Immunovant isn't playing the numbers game; they're playing the precision game. $200M behind a single target is either visionary or reckless."
The Lean Machine
For a company with $200M in funding, Immunovant operates with surprising efficiency. At 438 employees, they maintain a lean operational structure compared to traditional biotechs of similar capitalization. This suggests a heavy reliance on external partnerships and a focus on core R&D rather than building massive internal infrastructure. The revenue figure of $16.9M is likely milestone payments or early-stage collaboration revenue, not commercial sales—highlighting they are still in the pre-revenue growth phase.
Traffic & Visibility
With 11,120 monthly visits and a global rank hovering around 2.2M, Immunovant isn't a household name—and that's expected for a clinical-stage biotech. However, the traffic composition is telling: 43% direct traffic indicates strong brand recall among investors and industry insiders. The 41% organic search traffic is driven by high-intent keywords like 'immunovant pipeline' and 'immunovant revenue,' suggesting the audience isn't casual browsers; they are analysts, investors, and biotech professionals tracking the company's progress.
The tech stack reveals a modern, performant website built with Tailwind CSS and Bootstrap, utilizing jQuery for interactivity and GSAP for animations. It's a clean, corporate site designed for clarity rather than flashiness. The absence of social profiles in the data suggests a B2B/investor-focused digital strategy, prioritizing LinkedIn and press releases over Twitter or Instagram engagement.
- Single-target focus (FcRn) reduces complexity but increases risk.
- High capital efficiency: $200M funding vs. 438 employees.
- Investor-grade traffic: High direct traffic signals strong institutional interest.
- CEO Pete Salzmann leads a lean executive team focused on pipeline execution.
The Verdict: High Stakes, High Reward
Immunovant is a pure-play biotech for investors who believe in the FcRn mechanism. It's not for the faint of heart, but the capital efficiency and focus are compelling.
What tech stack does Immunovant use?
How much traffic does Immunovant get?
Traffic & Engagement
Traffic Sources
Where is Immunovant's audience located?
What keywords does Immunovant rank for?
5 keywordsHow is Immunovant's SEO?
Open Graph Image

https://d1io3yog0oux5.cloudfront.net/_2520548587927c961f4af0d7e7ad7451/immunovant/db/950/8034/social_image_resized.jpg
Meta Tags
Immunovant, Inc. (IMVT)
Immunovant, Inc.
H1 Tags
Schema Types
What is Immunovant's revenue?
Who works at Immunovant?
Loading leads...
What do customers think of Immunovant?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Immunovant
What is Immunovant's Revenue?
How fast is Immunovant growing?
What technologies does Immunovant use?
Who are Immunovant's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Immunovant?
Contact Information
Export immunovant.com Data
Download the complete tech stack, analytics, leads, and company data for immunovant.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About immunovant.com
Company Overview
Contact immunovant.com
Phone Numbers
Technology Stack
immunovant.com uses 13 technologies across their website including cdnjs, AWS CloudFront, Cloudflare, Google Tag Manager, Google Analytics, and more.
CDN
cdnjs
Cloud & Hosting
AWS CloudFront, Cloudflare
Analytics & Marketing
Google Tag Manager, Google Analytics
Web Standards
Twitter Cards, RSS, PWA
CSS Frameworks
Bootstrap, Tailwind CSS
JavaScript Libraries
AOS, GSAP, jQuery
Traffic & Audience
immunovant.com receives approximately 11.1K monthly visitors and ranks #2,215,539 globally. The website has a bounce rate of 39% with visitors viewing an average of 1.5 pages per visit. Users spend an average of 0:12 on the site.
The majority of immunovant.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is immunovant.com?
What technologies does immunovant.com use?
How do I contact immunovant.com?
How popular is immunovant.com?
Related Searches
This page provides publicly available information about immunovant.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit immunovant.com directly at https://immunovant.com.